Compound ID | 1529
Teicoplanin guanidine derivative 16e (Amide)
Class: Glycopeptide
| Agent Type: | Semisynthetic; Direct acting; |
| Spectrum of activity: | Gram-positive |
| Mechanism of action: | Cell wall synthesis inhibitor. Lipid II inhibitor |
| Target Pathogen: | Active against methicillin-resistant Staphylococcus aureus, Streptococcus epidermidis, and Enterococcus faecalis |
| Institute where first reported: | University of Debrecen, Hungary |
| Year first mentioned: | 2020 |
| Development status: | Experimental |
| External links: | |
| Citation: | https://www.nature.com/articles/s41429-020-0313-6 |
AntibioticDB is supported by GARDP.
If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions
The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.